Help KARA Do Something About Drugging Foster Kids (invitation to action)

Invisible Children readers know that psychotropic medications, especially “antipsychotics,” often are used to sedate and restrain problematic people, children especially—and not just any children, but foster children particularly, and most of all, foster children in so-called “group homes.”

Agreement is widespread that foster kids are over-medicated: too many, too young, too many drugs per child, on dosages that are too high and are maintained too long, often for years on end.

The PsychDrugs Action Campaign of the National Center for Youth Law invites you to help make positive changes now. Our contact information is at the bottom of this message.

Why Foster Children?

Foster children are a lucrative market for psychotropic drug sales. Unlike adults, they can’t say “no, I won’t take any more.” Their parents are in no position to object. Responsibility for prescribing is diffused confusingly among foster parents, caseworkers, child welfare supervisors, group home administrators, and prescribers. All are involved, but their roles in medication decisions are overlapping and ill-defined. It is easy for each to say, “it wasn’t my decision.”

One of the consequences is that in some states about half of children in group homes are medicated with psychotropic drugs. Many foster children are dozing through their childhoods and teenage years in a semi-sedated fog, a fog that is profitable for the drug industry and convenient for those administrators, staff, and foster parents who prefer to minimize demands on their time and attention.

The losers are the kids. A dozen years in a chemical straitjacket is no preparation for adult independence.

Mass Psychosis in the U.S – Important Insights Into Big Pharma, Psychotropics, & Children

Marcia Angell, former editor of the New England Journal of Medicine and a leading critic of the Big Pharma, puts it more bluntly: “Psychiatrists are in the pocket of industry.” Angell has pointed out that most of the Diagnostic and Statistical Manual of Mental Disorders (DSM), the bible of mental health clinicians, have ties to the drug industry. Likewise, a 2009 study showed that 18 out of 20 of the shrinks who wrote the American Psychiatric Association’s most recent clinical guidelines for treating depression, bipolar disorders, and schizophrenia had financial ties to drug companies.